| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Revenue | $821.3M | +4.1% |
| Cost of Revenue | $580.7M | +2.7% |
| Gross Profit | $240.6M | +7.7% |
| R&D Expense | $284K | -55.3% |
| SG&A Expense | $167.3M | -0.0% |
| Operating Income | -$2.28B | -1206.3% |
| Interest Expense | $41.3M | -16.1% |
| Pre-tax Income | -$2.30B | -824.6% |
| Income Tax | -$121.0M |
| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $221.7M | -2.9% |
| Short-term Investments | $34.7M | +7.8% |
| Accounts Receivable | $121.5M | +19.5% |
| Inventory | $270.9M | +7.5% |
| Current Assets | $688.6M | +1.6% |
| Total Assets | $2.07B | -50.9% |
| Current Liabilities | $280.3M | -6.3% |
| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$94.6M | -206.1% |
| Investing Cash Flow | -$46.7M | -136.4% |
| Financing Cash Flow | $133.5M | +277.6% |
| -354.7% |
| Net Income | -$2.19B | -792.6% |
| EPS (Basic) | -$2.46 | -645.5% |
| EPS (Diluted) | -$2.46 | -645.5% |
| Total Liabilities |
| $584.8M |
| -24.9% |
| Stockholders' Equity | $1.51B | -56.1% |